Historical record - last NADAC effective date: 2/17/2021
Product Information
ZOLMITRIPTAN 2.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $1.3217 per EA under NDC 69097086317. Its NADAC has been published 229 times since Oct 12, 2016.
FDA first approved this application on Apr 9, 2014.
Strength
2.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097086317
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/17/2021
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA204284FDA Approved
4/9/2014
On Market Since
7/20/2016
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 2.5 MG TABLET has been published 229 times since Oct 12, 2016, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3217 per EA |
|---|---|
| All-time high | $8.1820 (Nov 16, 2016) |
| All-time low | $0.9169 (Jun 17, 2020) |
| Median price | $4.8467 |
| Average price | $4.5826 |
| Largest weekly change | -78.2% (Feb 19, 2020) |
| Weeks tracked | 229 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-80.5%
Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG TABLET, manufactured by Cipla USA Inc., is $1.3217 per EA (NDC 69097086317), effective Feb 24, 2021.
How has the price of ZOLMITRIPTAN 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has declined 80.5%. It has been tracked across 229 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG TABLET?
Since Oct 12, 2016, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has ranged from a low of $0.9169 (Jun 17, 2020) to a high of $8.1820 (Nov 16, 2016), with a median of $4.8467 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLMITRIPTAN 2.5 MG TABLET, is $1.0228 per EA — about 23% below ZOLMITRIPTAN 2.5 MG TABLET.
Who manufactures ZOLMITRIPTAN 2.5 MG TABLET?
ZOLMITRIPTAN 2.5 MG TABLET (NDC 69097086317) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.